These data were confirmed by revising the published TCGA data set (http://cancergenome.nih.gov/dataportal/data/about), where FOXC1 expression in APL was 10-fold lower than that of other AML samples (Supplementary Figure 1). The gene discussed is FOXC1; the disease is acute promyelocytic leukemia.